Beta-3 Adrenoceptor Agonist for the Treatment of Bladder Dysfunction in Children: A Systematic Review and Meta-analysis.
Jin Kyu KimMark Jason De JesusMin Joon LeeJoana Dos SantosJun S DyJessica M MingMandy RickardArmando J LorenzoMichael E ChuaPublished in: The Journal of urology (2021)
ß3 agonists appear to be a promising, effective, and safe alternative/adjunctive therapy in management of pediatric NDO or overactive bladder, with improvements in both objective UDS parameters and subjective patient reported outcomes following their use.